Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jindra

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Vnitrni Lekarstvi|April 16, 2002
[Detection of cytomegalovirus infection with the polymerase chain reaction and antigenemia after allogenic bone marrow transplantation]P Simková, P Jindra, V Koza, et al.
Tissue Antigens|May 25, 2010
Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3)P Jindra, P Venigová, D Lysák, et al.
Bone Marrow Transplantation|July 1, 1997
Cyclophosphamide 3 g/m2 and G-CSF is an effective and safe outpatient-based PBSC mobilising regimen: a single centre experienceP Jindra, V Koza, P Cetkovský, et al.
Bone Marrow Transplantation|January 31, 1998
Individual criteria could be optimal for starting G-CSF application after autologous stem cell transplantationP Cetkovský, V Koza, P Jindra, et al.
Vnitrni Lekarstvi|November 20, 1998
[Monitoring cytomegalovirus infection using the 2-step nested polymerase chain reaction in patients with allogenic bone marrow transplantation]P Jindra, V Koza, P Cetkovský, et al.
Bone Marrow Transplantation|August 24, 1999
Autologous CD34+ cells transplantation after FAMP treatment in a patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complicationsP Jindra, V Koza, J Fiser, et al.
Bone Marrow Transplantation|March 24, 2005
Inefficiency of high-dose G-CSF alone as second mobilization regimen in fludarabin-cyclophosphamide-treated CLL patients who failed to mobilize after chemotherapy and G-CSFP Jindra, V Koza, D Lysák, et al.
Tissue Antigens|September 5, 2007
Identification of a novel HLA-DRB1*14 allele, HLA-DRB1*1458, by sequence-based typingT Karvunidis, P Jindra, G Fischer, et al.
Bone Marrow Transplantation|December 7, 2000
Frontline transplantation of autologous CD34+ selected blood cells for advanced mantle cell lymphoma: no evidence of long-term cure: a single centre experienceP Jindra, V Koza, M Svojgrová, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 2, 2007
Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantationT Reischig, P Jindra, O Hes, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Vnitrni Lekarstvi|April 16, 2002
[Detection of cytomegalovirus infection with the polymerase chain reaction and antigenemia after allogenic bone marrow transplantation]P Simková, P Jindra, V Koza, et al.
Tissue Antigens|May 25, 2010
Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3)P Jindra, P Venigová, D Lysák, et al.
Bone Marrow Transplantation|July 1, 1997
Cyclophosphamide 3 g/m2 and G-CSF is an effective and safe outpatient-based PBSC mobilising regimen: a single centre experienceP Jindra, V Koza, P Cetkovský, et al.
Bone Marrow Transplantation|January 31, 1998
Individual criteria could be optimal for starting G-CSF application after autologous stem cell transplantationP Cetkovský, V Koza, P Jindra, et al.
Vnitrni Lekarstvi|November 20, 1998
[Monitoring cytomegalovirus infection using the 2-step nested polymerase chain reaction in patients with allogenic bone marrow transplantation]P Jindra, V Koza, P Cetkovský, et al.
Bone Marrow Transplantation|August 24, 1999
Autologous CD34+ cells transplantation after FAMP treatment in a patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complicationsP Jindra, V Koza, J Fiser, et al.
Bone Marrow Transplantation|March 24, 2005
Inefficiency of high-dose G-CSF alone as second mobilization regimen in fludarabin-cyclophosphamide-treated CLL patients who failed to mobilize after chemotherapy and G-CSFP Jindra, V Koza, D Lysák, et al.
Tissue Antigens|September 5, 2007
Identification of a novel HLA-DRB1*14 allele, HLA-DRB1*1458, by sequence-based typingT Karvunidis, P Jindra, G Fischer, et al.
Bone Marrow Transplantation|December 7, 2000
Frontline transplantation of autologous CD34+ selected blood cells for advanced mantle cell lymphoma: no evidence of long-term cure: a single centre experienceP Jindra, V Koza, M Svojgrová, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 2, 2007
Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantationT Reischig, P Jindra, O Hes, et al.
Pageof 5